Filtros : "IQ-QBQ" "Financiamento NSFC" Removido: "BIOTECNOL" Limpar

Filtros



Refine with date range


  • Source: Frontiers Pharmacology. Unidade: IQ

    Subjects: SISTEMA NERVOSO CENTRAL, DOENÇAS DO SISTEMA NERVOSO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TANG, Yong et al. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.3389/fphar.2023.1355286. Acesso em: 24 maio 2024. , 2024
    • APA

      Tang, Y., Rubini, P., Sperlagh, B., & Ulrich, H. (2024). Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1355286
    • NLM

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 maio 24 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
    • Vancouver

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 maio 24 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
  • Source: Neurobiology of Disease. Unidade: IQ

    Subjects: TRANSTORNOS MENTAIS, DOENÇAS NEURODEGENERATIVAS, RECEPTORES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Purinergic receptors in cognitive disturbances. Neurobiology of Disease, v. 185, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.nbd.2023.106229. Acesso em: 24 maio 2024.
    • APA

      Illes, P., Ulrich, H., Chen, J. F., & Tang, Y. (2023). Purinergic receptors in cognitive disturbances. Neurobiology of Disease, 185, 1-16. doi:10.1016/j.nbd.2023.106229
    • NLM

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
    • Vancouver

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
  • Source: Drug Resistance Updates. Unidade: IQ

    Subjects: NEOPLASIAS, PURINAS, PROLIFERAÇÃO CELULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JIA, Wenhui et al. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, v. 70, p. 1-13 art. 100988, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.drup.2023.100988. Acesso em: 24 maio 2024.
    • APA

      Jia, W., Huang, Z., Zhou, L., Liou, Y. -C., Virgilio, F. D., Ulrich, H., et al. (2023). Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, 70, 1-13 art. 100988. doi:10.1016/j.drup.2023.100988
    • NLM

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
    • Vancouver

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: AÇÚCAR, CÉREBRO, RECEPTORES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAO, Xin et al. A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, v. 37, n. 5 p. 754–756, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12264-021-00692-x. Acesso em: 24 maio 2024.
    • APA

      Cao, X., Yin, H. -Y., Ulrich, H., Semyanov, A., & Tang, Y. (2021). A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, 37( 5 p. 754–756). doi:10.1007/s12264-021-00692-x
    • NLM

      Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2024 maio 24 ] Available from: https://doi.org/10.1007/s12264-021-00692-x
    • Vancouver

      Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2024 maio 24 ] Available from: https://doi.org/10.1007/s12264-021-00692-x
  • Source: Signal Transduction and Targeted Therapy. Unidade: IQ

    Subjects: PURINAS, DOENÇAS NEURODEGENERATIVAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HUANG, Zhao et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, v. 6, p. 1-20 art. 162, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41392-021-00553-z. Acesso em: 24 maio 2024.
    • APA

      Huang, Z., Xie, N., Illes, P., Virgilio, F. D., Ulrich, H., Semyanov, A., et al. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6, 1-20 art. 162. doi:10.1038/s41392-021-00553-z
    • NLM

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 maio 24 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
    • Vancouver

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 maio 24 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
  • Source: Purinergic Signalling. Unidade: IQ

    Subjects: RECEPTORES, ADENOSINA TRIFOSFATO, FARMACOLOGIA, BIOQUÍMICA, BIOLOGIA MOLECULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WANG, Tao et al. Optical control of purinergic signaling. Purinergic Signalling, v. 17, p. 385–392, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11302-021-09799-2. Acesso em: 24 maio 2024.
    • APA

      Wang, T., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2021). Optical control of purinergic signaling. Purinergic Signalling, 17, 385–392. doi:10.1007/s11302-021-09799-2
    • NLM

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 maio 24 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
    • Vancouver

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 maio 24 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
  • Source: Research. Unidade: IQ

    Subjects: PROTEÍNAS, MOLÉCULA, METAIS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUAN, Guodong et al. Highly dynamic polynuclear metal cluster revealed in a single metallothionein molecule. Research, v. 2021 p. 1-11 art. 9756945, 2021Tradução . . Disponível em: https://doi.org/10.34133/2021/9756945. Acesso em: 24 maio 2024.
    • APA

      Yuan, G., Curtolo, F., Deng, Y., Wu, T., Tian, F., Ma, Q., et al. (2021). Highly dynamic polynuclear metal cluster revealed in a single metallothionein molecule. Research, 2021 p. 1-11 art. 9756945. doi:10.34133/2021/9756945
    • NLM

      Yuan G, Curtolo F, Deng Y, Wu T, Tian F, Ma Q, Liu Y, Zuo J, Arantes GM, Zheng P. Highly dynamic polynuclear metal cluster revealed in a single metallothionein molecule [Internet]. Research. 2021 ; 2021 p. 1-11 art. 9756945[citado 2024 maio 24 ] Available from: https://doi.org/10.34133/2021/9756945
    • Vancouver

      Yuan G, Curtolo F, Deng Y, Wu T, Tian F, Ma Q, Liu Y, Zuo J, Arantes GM, Zheng P. Highly dynamic polynuclear metal cluster revealed in a single metallothionein molecule [Internet]. Research. 2021 ; 2021 p. 1-11 art. 9756945[citado 2024 maio 24 ] Available from: https://doi.org/10.34133/2021/9756945

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024